European Medicines Agency (EMA) Archives

Patient involvement in EMA regulatory committees

Medicines R&D

This article explores patient involvement in scientific regulatory committees in the EU, specifically in the activities of the European Medicines Association (EMA).

Marketing authorisation

Medicines R&D

Before a medicinal product can be marketed and sold, a marketing authorisation must be obtained from the relevent National Competent Authorities. The marketing authorisation application process can take one...

EMA Committees: Committee for Orphan Medicinal Products (COMP)

Medicines R&D

The EMA Committee for Orphan Medicinal Products (COMP) reviews applications for orphan-medicinal-product designation.

EMA Committees: Committee for Advanced Therapies (CAT)

Medicines R&D

The EMA Committee for Advanced Therapies (CAT) reviews the quality, safety, and efficacy of Advanced-Therapy Medicinal Products (ATMPs).

Tag - European Medicines Agency (EMA)

Patient involvement in EMA regulatory committees

Marketing authorisation

EMA Committees: Committee for Orphan Medicinal Products (COMP)

EMA Committees: Committee for Advanced Therapies (CAT)

Find Out More